Recently the effect of tumor marker on bone metastasis in breast cancer was regarded increasingly.
近年来，肿瘤标志物在乳腺癌骨转移中的作用日益受到重视。
The article reviewed the development of tumor marker research on diagnosis, treatment of bone metastasis in breast cancer.
对部分肿瘤标志物在乳腺癌骨转移诊断、治疗以及疗效监测等方面研究进展进行了综述。
Objective To introduce the current studies on bone biochemical markers in breast cancer with bone metastasis.
目的介绍骨生化指标在乳腺癌骨转移诊治中的应用及价值。
OBJECTIVE: To establish breast cancer cell strains of BSP with stable expression and observe the effect of BSP in the whole process of breast cancer bone metastasis.
目的：建立骨唾液蛋白的稳定表达乳腺癌细胞系，观察骨唾液蛋白在乳腺癌骨转移的整个过程中的作用。
ICTP was much more worthy than NTX in diagnosis of breast cancer with bone metastasis.
成骨型生化指标在乳腺癌骨转移诊治中的价值不大。
Our study suggested that the combination of chemotherapy and endocrine therapy was the best choice for treating bone metastasis in early breast cancer.
骨转移后进行综合治疗仍可取得良好疗效，其中初步显示化疗加内分泌治疗可能是骨转移综合治疗中疗效最佳的组合。
Conclusion bone biochemical markers can not replace the image exams and biopsy in diagnosing the bone metastasis of breast cancer, but may be one of the factors to get the early diagnosis.
结论骨生化指标尚不能取代影像学及骨活检在乳腺癌骨转移诊治中的地位。
Conclusion bone biochemical markers can not replace the image exams and biopsy in diagnosing the bone metastasis of breast cancer, but may be one of the factors to get the early diagnosis.
结论骨生化指标尚不能取代影像学及骨活检在乳腺癌骨转移诊治中的地位。
应用推荐